| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 206,657 | 206,041 | 185,932 | 208,861 | | Cost of Revenue | 16,950 | 49,470 | 38,064 | 43,583 | | | Gross Profit | 189,707 | 156,571 | 147,868 | 165,278 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 41,456 | 24,389 | 17,381 | 16,836 | | Non Recurring |
-
| 70,643 | 896,483 | 633,515 | | Others | 44,548 | 50,966 | 59,696 | 62,440 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 103,703 | 10,573 | (825,692) | (547,513) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (44,330) | 18,161 | 761 | (318,525) | | Earnings Before Interest And Taxes | 59,373 | 28,734 | (824,931) | (678,876) | | Interest Expense | 41,619 | 68,081 | 40,201 | 48,473 | | Income Before Tax | 17,754 | (39,347) | (865,132) | (727,349) | | Income Tax Expense | 15,595 | (18,897) | (297,823) | (259,209) | | Minority Interest | (4,411) |
-
|
-
| 2,621 | | | | Net Income From Continuing Ops | (2,252) | (20,450) | (567,309) | (465,519) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,252) | (20,450) | (567,309) | (465,519) | | Preferred Stock And Other Adjustments | 2,982 | (1,312) | (1,670) | (4,654) | | | Net Income Applicable To Common Shares | $730 | ($21,762) | ($568,979) | ($470,173) |
|
0.51% Nasdaq 
Income Statement
